UCLE · As filed with the SEC
US Nuclear income statement, by fiscal year
The statement as US Nuclear presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Consolidated Statements of Operations · USD
| USD | FY2025 Year ended Dec 31, 2025 | FY2024 Year ended Dec 31, 2024 |
|---|---|---|
| Sales | 2,168,999 | 2,190,398 |
| Cost of sales | 1,078,697 | 1,174,769 |
| Gross profit | 1,090,302 | 1,015,629 |
| Operating expenses: | ||
| Professional fees | 396,929 | 259,566 |
| Officer compensation | — | 100,000 |
| Payroll and related expense | 453,317 | 528,835 |
| Selling, general and administrative expenses | 1,048,981 | 1,662,381 |
| Impairment loss on goodwill | 130,514 | — |
| Total operating expenses | 2,029,741 | 2,550,782 |
| Loss from operations | (939,439) | (1,535,153) |
| Other income (expense) | ||
| Interest expense | (162,180) | (225,476) |
| Incentive expense | (24,000) | — |
| Loss on inventory write-down | (589,177) | — |
| Other income | 475,745 | 20,703 |
| Total other income (expense) | (299,612) | (204,773) |
| Loss before provision for income taxes | (1,239,051) | (1,739,926) |
| Net loss | (1,239,051) | (1,739,926) |
| Preferred stock dividends | (234,438) | (74,446) |
| Net loss attributed to common stockholders | (1,473,489) | (1,814,372) |
| Weighted average shares outstanding - basic (in Shares) | 60,486,788 | 46,763,793 |
| Weighted average shares outstanding - diluted (in Shares) | 60,486,788 | 46,763,793 |
| Loss per share - basic (in Dollars per share) | (0.02) | (0.04) |
| Loss per share - diluted (in Dollars per share) | 0.02 | 0.04 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.